Risk of Lung Cancer Recurrence Linked to ctDNA Levels
A new demonstrates the high sensitivity of the NeXT Personal test for detecting ctDNA in early-stage lung cancer.
Read MorePosted by Andy Lundin | Jan 15, 2025 | Lung Cancer, Molecular Diagnostics |
A new demonstrates the high sensitivity of the NeXT Personal test for detecting ctDNA in early-stage lung cancer.
Read MorePosted by Andy Lundin | Jan 10, 2025 | Lung Cancer |
The ORACLE test can predict lung cancer survival at diagnosis accurately, offering new hope for tailored treatments in stage 1 patients.
Read MorePosted by Andy Lundin | Jan 7, 2025 | Cancer |
A new biolaser-based method detects circulating tumor cells in pancreatic and lung cancer patients, improving early diagnosis and treatments.
Read MorePosted by Andy Lundin | Jan 6, 2025 | Accreditation |
2024 CAP Laboratory Accreditation Program checklists integrate key CLIA final rule changes, revised personnel requirements, and more.
Read MorePosted by Chris Wolski | Dec 27, 2024 | Lung Cancer |
The Nu.Q Cancer Test distinguished between malignant and benign pulmonary nodules detected by LDCT scans in suspected lung cancer.
Read More